RNA-Targeting CRISPR/CasRx system relieves disease symptoms in Huntington’s disease models
Abstract Background HD is a devastating neurodegenerative disorder caused by the expansion of CAG repeats in the HTT. Silencing the expression of mutated proteins is a therapeutic direction to rescue HD patients, and recent advances in gene editing technology such as CRISPR/CasRx have opened up new...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2025-01-01
|
| Seri Bilgileri: | Molecular Neurodegeneration |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s13024-024-00794-w |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|